Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Mitochondria in relation to cancer metastasis: introduction to a mini-review series.

Pedersen PL.

J Bioenerg Biomembr. 2012 Dec;44(6):615-7. doi: 10.1007/s10863-012-9470-z.

PMID:
22926290
3.

The cancer cell's "power plants" as promising therapeutic targets: an overview.

Pedersen PL.

J Bioenerg Biomembr. 2007 Feb;39(1):1-12. Review.

PMID:
17404823
4.

A translational study "case report" on the small molecule "energy blocker" 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside.

Ko YH, Verhoeven HA, Lee MJ, Corbin DJ, Vogl TJ, Pedersen PL.

J Bioenerg Biomembr. 2012 Feb;44(1):163-70. doi: 10.1007/s10863-012-9417-4. Epub 2012 Feb 11.

PMID:
22328020
5.

Mitochondrial dysfunction and cancer metastasis.

Chen EI.

J Bioenerg Biomembr. 2012 Dec;44(6):619-22. doi: 10.1007/s10863-012-9465-9. Review.

PMID:
22892817
6.

Mitochondria in relation to cancer metastasis.

Bhandary B, Marahatta A, Kim HR, Chae HJ.

J Bioenerg Biomembr. 2012 Dec;44(6):623-7. doi: 10.1007/s10863-012-9464-x. Review.

PMID:
22914881
7.

"Just Another Statistic"

Machtay M, Glatstein E.

Oncologist. 1998;3(3):III-IV.

PMID:
10388105
8.

Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Dittmar T, Heyder C, Gloria-Maercker E, Hatzmann W, Zänker KS.

Clin Exp Metastasis. 2008;25(1):11-32. Epub 2007 Sep 8. Review.

PMID:
17828597
9.

Molecular correlates of site-specific metastasis.

Dai CY, Haqq CM, Puzas JE.

Semin Radiat Oncol. 2006 Apr;16(2):102-10. Review.

PMID:
16564445
10.

Anticancer Drug Development: The Way Forward.

Connors T.

Oncologist. 1996;1(3):180-181.

11.

Beware the Medical-Industrial Complex.

Stevens CW, Glatstein E.

Oncologist. 1996;1(4):IV-V.

PMID:
10388005
13.

A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.

Picon A, Gold LI, Wang J, Cohen A, Friedman E.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):497-504.

14.
15.

The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.

Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R.

Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Review.

PMID:
20206201
16.

Inhibition of the arrest of hematogenously disseminated tumor cells.

Tsubura E, Yamashita T, Sone S.

Cancer Metastasis Rev. 1983;2(3):223-37. Review.

PMID:
6367967
17.
19.

Reactive oxygen species in tumor metastasis.

Nishikawa M.

Cancer Lett. 2008 Jul 18;266(1):53-9. doi: 10.1016/j.canlet.2008.02.031. Epub 2008 Mar 24. Review.

PMID:
18362051
20.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017

Supplemental Content

Support Center